Founder and President


Teresa Norris is the Founder and President of HPV Global Action, a National, bilingual registered charity since 2006. As a Sexual Health Specialist with expertise in HPV, she appears regularly nationally and internationally, speaking in public, media, and academic forums on HPV-related issues & sexual health.

The inception of Teresa’s passion for sexual health education stems from the loss of her best friend to cervical cancer at the age of 24 in 2001. Teresa then launched an awareness campaign through a Princess Margaret Hospital Foundation fundraiser in 2002 to raise awareness about HPV, which quickly included scholar tours across the country and prompted public speaking appearances around the globe. This led to the beginning of a career, to date reaching millions of people.

Delivering awareness and spreading vital sexual health education to hundreds of Canadian schools of every demographic and age across the country and overseas is her day-to-day work. Her focus is on bringing leaders together to communicate and provide solutions regarding worldwide HPV prevention and cervical cancer screening challenges. She works with National and International leaders to improve provincial, federal, and global decisions and outcomes, particularly on HPV prevention and screening policies.



Ensuring a Successful Transition From Cytology to Human Papillomavirus
Gabrielle Griffin-Mathieu; Ben Haward; Ovidiu Tatar; Patricia Zhu; Samara Perez; Gilla K Shapiro; Emily McBride; Erika L Thompson; Laurie W Smith; Aisha K Lofters; Ellen M Daley; Juliet R Guichon; Jo Waller; Marc Steben; Kathleen M Decker; Marie-Helene Mayrand; Julia M L Brotherton; Gina S Ogilvie; Gregory D Zimet; Teresa Norris; Zeev Rosberger;

WHO calls ISSVD to action on elimination of female genital Shistosomiasis
Marc Steben, MD; Eyrun Floerecke Kjetland; Teresa Norris

COVID-19 Won’t Be the Last (Or Worst) Pandemic: It’s Time to Build Resilience Into Our Cervical Cancer Elimination Goals
Marc Steben, MD; Teresa Norris; Zeev Rosberger, PhD

Canada’s Role in Accelerating Global Elimination of Cervical Cancer
Marc Steben, MD; George Wurtak, MED; Silvia de Sanjosé, MD; Marina Salvadori, MD; Francois Coutlée, MD; Alberto Severini, MD; Salah Mahmud, MD; Eduardo Franco, doctorat en santé publique; Ann N. Burchell, PhD; Hélène M. Gagné, MD; James Bentley, MBBS; Laurie Elit, MD; Magali Lecavalier-Barsoum, MD; Deborah Dudgeon, MD; Nitika Pant Pai, MD; Angela Karellis, MSc; Catherine Popadiuk, MD; Laurie W. Smith, IA certifiée.Inf.; Teresa Norris; Amelie McFadyen, MA; Jennifer Blake, MD; Roger Simard, B. Pharm;

Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy
Silvia de Sanjosé,1,2 Rebecca B Perkins,3 Nicole Campos,4 Federica Inturrisi,1 Didem Egemen,1 Brian Befano,5,6 Ana Cecilia Rodriguez,1 Jose Jerónimo,1 Li C Cheung,1 Kanan Desai,1 Paul Han,7 Akiva P Novetsky,8 Abigail Ukwuani,1 Jenna Marcus,9 Syed Rakin Ahmed,10,11,12,13 Nicolas Wentzensen,1 Jayashree Kalpathy-Cramer,10,14 and Mark Schiffman1, On behalf of the PAVE Study Group

A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec
Zeev Rosberger; Marc Steben; Teresa Norris; Amelie McFadyen ; Gilla K. Shapiro